Lésions malpighiennes intra-épithéliales du col utérin : Questions médicales fréquentes
Nom anglais: Squamous Intraepithelial Lesions of the Cervix
Descriptor UI:D065310
Tree Number:C23.149.688.500
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lésions malpighiennes intra-épithéliales du col utérin : Questions médicales les plus fréquentes",
"headline": "Lésions malpighiennes intra-épithéliales du col utérin : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lésions malpighiennes intra-épithéliales du col utérin : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-28",
"dateModified": "2025-04-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lésions malpighiennes intra-épithéliales du col utérin"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lésions malpighiennes intra-épithéliales",
"url": "https://questionsmedicales.fr/mesh/D000081483",
"about": {
"@type": "MedicalCondition",
"name": "Lésions malpighiennes intra-épithéliales",
"code": {
"@type": "MedicalCode",
"code": "D000081483",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.149.688"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Lésions malpighiennes intra-épithéliales du col utérin",
"alternateName": "Squamous Intraepithelial Lesions of the Cervix",
"code": {
"@type": "MedicalCode",
"code": "D065310",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hyun-Soo Kim",
"url": "https://questionsmedicales.fr/author/Hyun-Soo%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea."
}
},
{
"@type": "Person",
"name": "Lihui Wei",
"url": "https://questionsmedicales.fr/author/Lihui%20Wei",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, P.R. China."
}
},
{
"@type": "Person",
"name": "Zhongqiu Lin",
"url": "https://questionsmedicales.fr/author/Zhongqiu%20Lin",
"affiliation": {
"@type": "Organization",
"name": "Department of Gynecological Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, PR China."
}
},
{
"@type": "Person",
"name": "Rita Maira Zanine",
"url": "https://questionsmedicales.fr/author/Rita%20Maira%20Zanine",
"affiliation": {
"@type": "Organization",
"name": "Department of Gynecology and Obstetrics, Lower Genital Tract Disease and Colposcopy Sector, Clinics Hospital of the University of Paraná, Curitiba, PR, Brazil."
}
},
{
"@type": "Person",
"name": "Hyunjin Kim",
"url": "https://questionsmedicales.fr/author/Hyunjin%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Personalized approach to management of high-grade squamous intraepithelial lesion.",
"datePublished": "2022-07-29",
"url": "https://questionsmedicales.fr/article/35908683",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pdpdt.2022.103038"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diagnosis and Management of Cervical Squamous Intraepithelial Lesions in Pregnancy and Postpartum.",
"datePublished": "2024-03-29",
"url": "https://questionsmedicales.fr/article/38547493",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/AOG.0000000000005566"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association Between Recurrence of High-grade Squamous Intraepithelial Lesions of the Uterine Cervix and p16, C-myc and PIK3CA Proteins-A Single-center Retrospective Study.",
"datePublished": "2024-10-09",
"url": "https://questionsmedicales.fr/article/39384698",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12013-024-01548-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Stratified Mucin-Producing Intraepithelial Lesion of the Cervix in an HPV- 16 Positive Woman: A Rare Encounter.",
"datePublished": "2024-01-29",
"url": "https://questionsmedicales.fr/article/38288809",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2174/0118715265284722240110114107"
}
},
{
"@type": "ScholarlyArticle",
"name": "Underdiagnosis of cervical intraepithelial neoplasia by colposcopy and its association with thin high‑grade squamous intraepithelial lesions.",
"datePublished": "2023-05-19",
"url": "https://questionsmedicales.fr/article/37274470",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3892/ol.2023.13873"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Résultats morphologiques et microscopiques",
"item": "https://questionsmedicales.fr/mesh/D065308"
},
{
"@type": "ListItem",
"position": 4,
"name": "Lésions malpighiennes intra-épithéliales",
"item": "https://questionsmedicales.fr/mesh/D000081483"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lésions malpighiennes intra-épithéliales du col utérin",
"item": "https://questionsmedicales.fr/mesh/D065310"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lésions malpighiennes intra-épithéliales du col utérin - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lésions malpighiennes intra-épithéliales du col utérin",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lésions malpighiennes intra-épithéliales du col utérin",
"description": "Comment diagnostique-t-on ces lésions ?\nQuels tests sont utilisés pour le dépistage ?\nQuels sont les résultats possibles d'un frottis ?\nQuand faut-il répéter le frottis ?\nQuel rôle joue la biopsie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D065310?page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lésions malpighiennes intra-épithéliales du col utérin",
"description": "Quels symptômes peuvent indiquer des lésions ?\nLes douleurs pelviennes sont-elles un symptôme ?\nPeut-on avoir des symptômes urinaires ?\nLes pertes vaginales sont-elles un signe ?\nLes lésions provoquent-elles des démangeaisons ?",
"url": "https://questionsmedicales.fr/mesh/D065310?page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lésions malpighiennes intra-épithéliales du col utérin",
"description": "Comment prévenir les lésions malpighiennes ?\nQuel est le rôle du vaccin HPV ?\nÀ quel âge commencer le dépistage ?\nLes rapports protégés aident-ils à prévenir ?\nFaut-il éviter certains comportements ?",
"url": "https://questionsmedicales.fr/mesh/D065310?page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lésions malpighiennes intra-épithéliales du col utérin",
"description": "Quels traitements sont disponibles pour les lésions ?\nQuand faut-il envisager une conisation ?\nLa cryothérapie est-elle efficace ?\nQuels sont les effets secondaires des traitements ?\nFaut-il un suivi après traitement ?",
"url": "https://questionsmedicales.fr/mesh/D065310?page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lésions malpighiennes intra-épithéliales du col utérin",
"description": "Quelles sont les complications possibles ?\nLes lésions peuvent-elles récidiver ?\nY a-t-il des risques lors de la grossesse ?\nLes traitements affectent-ils la fertilité ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D065310?page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lésions malpighiennes intra-épithéliales du col utérin",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe nombre de partenaires sexuels influence-t-il le risque ?\nLe système immunitaire affecte-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D065310?page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on ces lésions ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par un frottis cervical et une colposcopie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le dépistage ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le test Pap et le test HPV sont couramment utilisés pour le dépistage."
}
},
{
"@type": "Question",
"name": "Quels sont les résultats possibles d'un frottis ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les résultats peuvent être normaux, ASCUS, LSIL, HSIL ou cancer."
}
},
{
"@type": "Question",
"name": "Quand faut-il répéter le frottis ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est recommandé de répéter le frottis tous les 3 ans après 21 ans."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la biopsie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biopsie permet de confirmer la présence et le type de lésions."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer des lésions ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Souvent, il n'y a pas de symptômes, mais des saignements anormaux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les douleurs pelviennes sont-elles un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les douleurs pelviennes ne sont pas typiques des lésions malpighiennes."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes urinaires ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes urinaires ne sont généralement pas associés à ces lésions."
}
},
{
"@type": "Question",
"name": "Les pertes vaginales sont-elles un signe ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des pertes vaginales inhabituelles peuvent survenir, mais ce n'est pas spécifique."
}
},
{
"@type": "Question",
"name": "Les lésions provoquent-elles des démangeaisons ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les démangeaisons ne sont pas un symptôme courant des lésions malpighiennes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les lésions malpighiennes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par le dépistage régulier et la vaccination contre le HPV."
}
},
{
"@type": "Question",
"name": "Quel est le rôle du vaccin HPV ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le vaccin HPV réduit le risque de développer des lésions précoces et le cancer."
}
},
{
"@type": "Question",
"name": "À quel âge commencer le dépistage ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage doit commencer à 21 ans, indépendamment de l'activité sexuelle."
}
},
{
"@type": "Question",
"name": "Les rapports protégés aident-ils à prévenir ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les rapports protégés réduisent le risque de transmission du HPV."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certains comportements ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et avoir plusieurs partenaires sexuels peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les lésions ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la surveillance, la cryothérapie ou la conisation."
}
},
{
"@type": "Question",
"name": "Quand faut-il envisager une conisation ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La conisation est envisagée pour les lésions HSIL ou si le suivi est difficile."
}
},
{
"@type": "Question",
"name": "La cryothérapie est-elle efficace ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la cryothérapie est efficace pour détruire les cellules anormales."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des saignements et des douleurs légères."
}
},
{
"@type": "Question",
"name": "Faut-il un suivi après traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est essentiel pour surveiller les récidives."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent le développement d'un cancer du col de l'utérus."
}
},
{
"@type": "Question",
"name": "Les lésions peuvent-elles récidiver ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les lésions peuvent récidiver, surtout si elles ne sont pas traitées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques lors de la grossesse ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les lésions peuvent nécessiter un suivi accru pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Les traitements affectent-ils la fertilité ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains traitements, comme la conisation, peuvent affecter la fertilité."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical régulier et des traitements appropriés."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'infection par le HPV et le tabagisme."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout après 30 ans."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer du col augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le nombre de partenaires sexuels influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir de nombreux partenaires sexuels augmente le risque d'infection par le HPV."
}
},
{
"@type": "Question",
"name": "Le système immunitaire affecte-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un système immunitaire affaibli augmente le risque de développer des lésions."
}
}
]
}
]
}
Cervical cancer ranks 4th place among malignant neoplasms in the world in 2020. HPV is the main reason for cervical cancer. The «Gold standard» of cervical screening is an «HPV-testing + PAP-test» co-...
Perinatal care provides important health care opportunities for many individuals at risk for cervical cancer. Pregnancy does not alter cervical cancer screening regimens. ASCCP risk-based management h...
Cervical high-grade squamous intraepithelial lesions (HSIL) are one of the common types of cervical cancer precancerous changes, and HPV16/18 positivity is a risk factor for HSIL recurrence. By detect...
Cervical cancer is the fourth most common cancer among women globally and has a strong association with Human Papillomavirus (HPV) infection. Stratified mucinproducing intraepithelial lesion (SMILE), ...
The present case report briefs the finding of a 39-year-old woman who presented to the gynecological outpatient department with complaints of vaginal discharge for 6-8 months. She had no history of ir...
The SMILE variant of AIS is a rare cervical precancerous lesion characterized by the morphological overlap of both squamous intraepithelial lesions and AIS. It is often difficult to diagnose on Pap sm...
SMILE is a rare variant of AIS, which is often missed on cytological screening of the cervix. It is commonly associated with high-risk types of HPV. Hence, incorporating HPV testing in the screening o...
The relationship between the thickness of the epithelium and the colposcopic diagnosis is controversial. The present study was conducted to determine whether colposcopic underdiagnosis of cervical int...
Laminin receptor 1 (LAMR) may have a role in the progression of premalignant squamous epithelial lesions to cervical cancer. Therefore, we aimed to investigate the expression of laminin receptor 1 (LA...
We aimed to evaluate the efficacy and safety of HiPorfin-photodynamic therapy (PDT) in women with vaginal high-grade squamous intraepithelial Lesion (HSIL)....
Retrospective analysis of eighteen patients with vaginal HSIL received HiPorfin-PDT between June 2019 and May 2023. Illumination with a 630-nm laser light was applied to the lesions 48-72 h after intr...
The mean age of the 18 patients was 45.8 years (range, 24 to 63). The complete response (CR) rate was 66.7% (12/18), 83.3% (15/18) and 83.3% (15/18) at 3, 6 and 12 months after PDT, respectively. Pati...
HiPorfin-PDT may be an effective alternative treatment for vaginal HSIL for organ-saving and sexual function protection....
To evaluate the clinical efficacy and safety of HiPorfin® photodynamic therapy (PDT) in the treatment of young women at reproductive age with high-grade squamous intraepithelial lesion (HSIL) of the c...
Prospective study of 41 patients aged 28.8±4.6 years old with cervical intraepithelial neoplasia (CIN) Ⅱ-Ⅲ at Peking University Shenzhen Hospital from March 2019 to January 2023. HiPorfin® (2mg/kg) wa...
All 41 patients with no recurrence had been observed at least 12 months follow-up period after PDT. The number of nulliparous women was 30 (30/41, 73.2%). CIN Ⅱ were 22 cases (22/41,53.7%) and CIN Ⅲ w...
HiPorfin-PDT is a promising and organ-saving approach for cervical HSIL, which also eradicates HPV infection effectively and can be a beacon of hope for the young women with fertility preservation req...
Electroconization of the uterine cervix (LEEP/LLETZ) is an appropriate and sufficient procedure for high-grade squamous epithelial lesion - HSIL. Negative margins are considered fundamental for confir...
The study has comprised 781 patients aged 18-85 - the research group was composed of 140 (17.93%) patients after incomplete conization and the control group of 641 (82.17%) patients after the complete...
The statistical analysis results don't indicate a statistical significance between the frequency of HSIL in groups. HPV infection has increased the risk of persistent/recurrent lesions by 38 times, co...
Close follow-up instead of inconsiderate repeat procedures should be taken under consideration among patients of reproductive age after incomplete conization of the cervix. HPV typing may be an essent...
Identification of HPV infection is usually performed on cytological specimens, despite the often transient virus types. HPV profile analysis of pathologically confirmed lesions can also be performed o...